Abstract
Photodynamic therapy (PDT) is a non-invasive therapeutic technique used in the treatment of many cancers, including head and neck cancers. PDT is a two-step process: the patient is first given a drug (“photosensitizing agent”) that preferentially accumulates in the tumor. Light is then applied to the treatment site in order to active the drug, in turn leading to tumor destruction. A number of photosensitizing agents and light sources are used clinically for treating head and neck cancers. The PDT technique has been shown to be effective for treating premalignant lesions, early stage malignant tumors, and secondary or recurrent head and neck squamous cell carcinomas, as well as for aesthetic and cosmetic purposes. Additionally, a number of different head and neck tumor subtypes (larynx, oral cavity, neck, pharynx, etc.) have been successfully treated with PDT. This chapter serves to provide a general background of the PDT technique and discusses how PDT is currently used clinically to treat head and neck cancers. The future prospects of PDT in the treatment of head and neck cancers will also be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 5-ALA:
-
5-Aminolevulinic acid
- Chlorin e6-PVP:
-
1,3,5,8-tetramethyl-4-ethyl-2-vinyl-klorin-6-carbonic-acetic-7-propion acid sodium-vapor salt
- Cis:
-
Carcinoma in situ
- CO2 :
-
Carbon dioxide
- EU:
-
European Union
- FDA:
-
Food and Drug Administration
- H2O2 :
-
Hydrogen peroxide
- H&N:
-
Head and neck
- HNSCC:
-
Head and neck squamous cell carcinoma
- HpD:
-
Hematoporphyrin derivative
- HPPH:
-
2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
- InGaAlP:
-
Indium-Gallium-Aluminum-Phosphide
- IPDT:
-
Interstitial photodynamic therapy
- IPL:
-
Intense pulsed light
- KTP:
-
Potassium-Titanyl-Phosphate
- LEDs:
-
Light emitting diodes
- MAL:
-
Methyl ester-aminolevulinate
- mTHPC:
-
m-Tetrahydroxyphenylchlorin
- O2 •- :
-
Superoxide anion radical
- 1O2 :
-
Singlet oxygen
- 3O2 :
-
Triplet ground state molecular oxygen
- OH• :
-
Hydroxyl radical
- PDT:
-
Photodynamic Therapy
- PPIX:
-
Protoporphyrin IX
- PS:
-
Photosensitizer
- ROS:
-
Reactive oxygen species
- S0 :
-
Ground state
- S1 :
-
Excited ground state
- T1 :
-
Excited triplet state
- TNM:
-
Tumor, Node, Metastases
- UV:
-
Ultraviolet
References
Bredell MG, Besic E, Maake C, Walt H (2010) The application and challenges of clinical PD-PDT in the head and neck region: a short review. J Photochem Photobiol B 101(3):185–190
Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61(4):250–281
Fayter D, Corbett M, Heirs M, Fox D, Eastwood A (2010) A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett’s oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol Assess 14(37):1–288
Silva JN, Filipe P, Morliere P, Maziere JC, Freitas JP, Gomes MM, Santus R (2008) Photodynamic therapy: dermatology and ophthalmology as main fields of current applications in clinic. Biomed Mater Eng 18(4–5):319–327
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90(12):889–905
Garg AD, Nowis D, Golab J, Agostinis P (2010) Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis 15(9):1050–1071
Juarranz A, Jaen P, Sanz-Rodriguez F, Cuevas J, Gonzalez S (2008) Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 10(3):148–154
Biel MA (2010) Photodynamic therapy of head and neck cancers. Methods Mol Biol 635:281–293
Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387
Lee J, Moon C (2011) Current status of experimental therapeutics for head and neck cancer. Exp Biol Med (Maywood) 236(4):375–389
Dysart JS, Patterson MS (2005) Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys Med Biol 50(11):2597–2616
Juzeniene A, Nielsen KP, Moan J (2006) Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol 25(1–2):7–28
Castano AP, Demidova TN, Hamblin MR (2004) Mechanisms in photodynamic therapy: part one–photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther 1:279–293
Robertson CA, Evans DH, Abrahamse H (2009) Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 96(1):1–8
Macdonald IJ, Dougherty TJ (2001) Basic principles of photodynamic therapy. J Porphyrins Phthalocyanines 5(2):105–129
Sayre RM, Dowdy JC, Gottschalk RW (2011) Comparative effectiveness of clinically used light sources for cutaneous protoporphyrin IX-based photodynamic therapy. J Cosmet Laser Ther 13(2):63–68
Calzavara-Pinton PG, Venturini M, Sala R (2007) Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology. J Eur Acad Dermatol Venereol 21(3):293–302
Qiang YG, Zhang XP, Li J, Huang Z (2006) Photodynamic therapy for malignant and non-malignant diseases: clinical investigation and application. Chin Med J (Engl) 119(10):845–857
Babilas PH (2010) Light-assisted therapy in dermatology: the use of intense pulsed light (IPL). Med Laser Appl 25:61–69
Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2004) Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci 19(3):139–149
Szeimies RM, Morton CA, Sidoroff A, Braathen LR (2005) Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol 85(6):483–490
Brancaleon L, Moseley H (2002) Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 17(3):173–186
Issa MC, Manela-Azulay M (2010) Photodynamic therapy: a review of the literature and image documentation. An Bras Dermatol 85(4):501–511
Allison RR, Sibata CH (2010) Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn Ther 7(2):61–75
DeRosa MC, Crutchley RJ (2002) Photosensitized singlet oxygen and its applications. Coord Chem Rev 233–234:351–371
Darwent JR, Douglas P, Harriman A, Porter G, Richoux M-C (1982) Metal phthalocyanines and porphyrins as photosensitizers for reduction of water to hydrogen. Coord Chem Rev 44(1):83–126
Nifiatis F, Athas JC, Gunaratne KDD, Gurung Y, Monette KM, Shivokevich PJ (2011) Substituent effects of porphyrin on singlet oxygen generation quantum yields. Open Spectrosc J 5:1–12
Dougherty TJ, Potter WR, Weishaupt KR (1984) The structure of the active component of hematoporphyrin derivative. Prog Clin Biol Res 170:301–314
Dougherty TJ (1993) Photodynamic therapy. Photochem Photobiol 58(6):895–900
Allison RR, Sibata CH (2008) Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question. Photodiagnosis Photodyn Ther 5(2):112–119
Mitra S, Foster TH (2005) Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin. Photochem Photobiol 81(4):849–859
Heinemann IU, Jahn M, Jahn D (2008) The biochemistry of heme biosynthesis. Arch Biochem Biophys 474:238–251
Musiol R, Serda M, Polanski J (2011) Prodrugs in photodynamic anticancer therapy. Curr Pharm Des 17(32):3548–3559
Bellnier DA, Greco WR, Nava H, Loewen GM, Oseroff AR, Dougherty TJ (2006) Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol 57(1):40–45
Loewen GM, Pandey R, Bellnier D, Henderson B, Dougherty T (2006) Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med 38(5):364–370
Filonenko EV, Sokolov VV, Chissov VI, Lukyanets EA, Vorozhtsov GN (2008) Photodynamic therapy of early esophageal cancer. Photodiagnosis Photodyn Ther 5(3):187–190
Stranadko EF, Garbuzov MI, Zenger VG, Nasedkin AN, Markichev NA, Riabov MV, Leskov IV (2001) Photodynamic therapy of recurrent and residual oropharyngeal and laryngeal tumors. Vestn Otorinolaringol 3:36–39
Chin WW, Lau WK, Heng PW, Bhuvaneswari R, Olivo M (2006) Fluorescence imaging and phototoxicity effects of new formulation of chlorine 6-polyvinylpyrrolidone. J Photochem Photobiol B 84(2):103–110
Gold MH (2009) Fractionated aminolevulinic acid-photodynamic therapy (PDT) provides additional evidence for the use of PDT for non-melanoma skin cancer. J Eur Acad Dermatol Venereol 23(5):571–572
Gold MH (2009) Therapeutic and aesthetic uses of photodynamic therapy part five of a five-part series: ALA-PDT and MAL-PDT what makes them different. J Clin Aesthet Dermatol 2(2):44–47
Gold MH (2009) Therapeutic and aesthetic uses of photodynamic therapy part five of a five-part series: ALA-PDT in clinical practice how one clinician performs this procedure. J Clin Aesthet Dermatol 2(1):32–35
Casas A, Batlle A (2002) Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr Med Chem Anticancer Agents 2(4):465–475
Donnelly RF, McCarron PA, Woolfson AD (2008) Derivatives of 5-aminolevulinic acid for photodynamic therapy. Perspect Med Chem 1:49–63
Lopez RF, Lange N, Guy R, Bentley MV (2004) Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv Drug Deliv Rev 56(1):77–94
Firczuk M, Winiarska M, Szokalska A, Jodlowska M, Swiech M, Bojarczuk K, Salwa P, Nowis D (2011) Approaches to improve photodynamic therapy of cancer. Front Biosci 16:208–224
Morosini V, Bastogne T, Frochot C, Schneider R, Francois A, Guillemin F, Barberi-Heyob M (2011) Quantum dot-folic acid conjugates as potential photosensitizers in photodynamic therapy of cancer. Photochem Photobiol Sci 10(5):842–851
O’Connor AE, Gallagher WM, Byrne AT (2009) Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 85(5):1053–1074
Samia AC, Dayal S, Burda C (2006) Quantum dot-based energy transfer: perspectives and potential for applications in photodynamic therapy. Photochem Photobiol 82(3):617–625
Vesper BJ, Barrett AGM, Hoffman BH, Radosevich JA (2009) Porphyrazine anti-tumor agents. In: Mitchem BH, Shamham CL (eds) Clinical chemistry research. Nova, New York, pp 281–300
Biel MA (2006) Advances in photodynamic therapy for the treatment of head and neck cancers. Lasers Surg Med 38(5):349–355
Biel MA (2007) Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol 83(5):1063–1068
Konopka K, Goslinski T (2007) Photodynamic therapy in dentistry. J Dent Res 86(8):694–707
Schweitzer VG, Somers ML (2010) PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx. Lasers Surg Med 42(1):1–8
Biel MA (1994) Photodynamic therapy and the treatment of neoplastic diseases of the larynx. Laryngoscope 104(4):399–403
Biel MA (1995) Photodynamic therapy of head and neck cancers. Semin Surg Oncol 11(5):355–359
Biel MA (1998) Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 108(9):1259–1268
Feyh J, Goetz A, Muller W, Konigsberger R, Kastenbauer E (1990) Photodynamic therapy in head and neck surgery. J Photochem Photobiol B 7(2–4):353–358
Feyh J, Gutmann R, Leunig A (1993) Photodynamic laser therapy in the field of otorhinolaryngology. Laryngorhinootologie 72(6):273–278
Freche C, De Corbiere S (1990) Use of photodynamic therapy in the treatment of vocal cord carcinoma. J Photochem Photobiol B 6(3):291–296
Gluckman JL (1991) Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncology? Reflections on a 5-year experience. Laryngoscope 101(1 Pt 1):36–42
Grant WE, Hopper C, Speight PM, Macrobert AJ, Bown SG (1993) Photodynamic therapy of malignant and premalignant lesions in patients with ‘field cancerization’ of the oral cavity. J Laryngol Otol 107(12):1140–1145
Grossweiner LI, Hill JH, Lobraico RV (1987) Photodynamic therapy of head and neck squamous cell carcinoma: optical dosimetry and clinical trial. Photochem Photobiol 46(5):911–917
Keller GS, Doiron DR, Fisher GU (1985) Photodynamic therapy in otolaryngology–head and neck surgery. Arch Otolaryngol 111(11):758–761
Schweitzer VG (1990) Photodynamic therapy for treatment of head and neck cancer. Otolaryngol Head Neck Surg 102(3):225–232
Schweitzer VG (2001) PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 29(4):305–313
Wenig BL, Kurtzman DM, Grossweiner LI, Mafee MF, Harris DM, Lobraico RV, Prycz RA, Appelbaum EL (1990) Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 116(11):1267–1270
Zhao FY, Zhang KH, Ma DQ, He ZQ, Chen S, Ni XM, Yu GY (1989) Treatment of 570 cases of oral squamous cell carcinoma. Ann Acad Med Singapore 18(5):533–536
Zhao FY, Zhang KH, Huang HN, Sun KH, Ling QB, Xu BO (1986) Use of haematoporphyrin derivative as a sensitizer for radiotherapy of oral and maxillofacial tumours: a preliminary report. Lasers Med Sci 1(4):253–256
Kulapaditharom B, Boonkitticharoen V (1999) Photodynamic therapy for residual or recurrent cancer of the nasopharynx. J Med Assoc Thai 82(11):1111–1117
Kulapaditharom B, Boonkitticharoen V (2000) Photodynamic therapy in management of head and neck cancers and precancerous lesions. J Med Assoc Thai 83(3):249–258
Copper MP, Triesscheijn M, Tan IB, Ruevekamp MC, Stewart FA (2007) Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx. Clin Otolaryngol 32(3):185–189
Karakullukcu B, van Oudenaarde K, Copper MP, Klop WM, van Veen R, Wildeman M, Bing Tan I (2011) Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients. Eur Arch Otorhinolaryngol 268(2):281–288
Copper MP, Tan IB, Oppelaar H, Ruevekamp MC, Stewart FA (2003) Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129(7):709–711
Dilkes MG, Alusi G, Djaezeri BJ (1999) The treatment of head and neck cancer with photodynamic therapy: clinical experience. Rev Contemp Pharmacother 10(1):47–57
Dilkes MG, Benjamin E, Ovaisi S, Banerjee AS (2003) Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases. J Laryngol Otol 117(9):713–717
Dilkes MG, DeJode ML, Gardiner Q, Kenyon GS, McKelvie P (1995) Treatment of head and neck cancer with photodynamic therapy: results after one year. J Laryngol Otol 109(11):1072–1076
Dilkes MG, DeJode ML, Rowntree-Taylor A, McGilligan JA, Kenyon GS, McKelvie P (1996) m-THPC photodynamic therapy for head and neck cancer. Lasers Med Sci 11(1):23–29
Fan KF, Hopper C, Speight PM, Buonaccorsi GA, Bown SG (1997) Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int J Cancer 73(1):25–32
Hopper C, Kubler A, Lewis H, Tan IB, Putnam G (2004) mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 111(1):138–146
Kubler AC, de Carpentier J, Hopper C, Leonard AG, Putnam G (2001) Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy. Int J Oral Maxillofac Surg 30(6):504–509
Savary JF, Monnier P, Fontolliet C, Mizeret J, Wagnieres G, Braichotte D, van den Bergh H (1997) Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin. Arch Otolaryngol Head Neck Surg 123(2):162–168
Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG (1996) Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer 78(7):1374–1383
Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG (1993) Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet 342(8864):147–148
Sieron A, Namyslowski G, Misiolek M, Adamek M, Kawczyk-Krupka A (2001) Photodynamic therapy of premalignant lesions and local recurrence of laryngeal and hypopharyngeal cancers. Eur Arch Otorhinolaryngol 258(7):349–352
Kubler A, Haase T, Rheinwald M, Barth T, Muhling J (1998) Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. Int J Oral Maxillofac Surg 27(6):466–469
Fauteck JD, Ackermann G, Birkel M, Breuer M, Moor AC, Ebeling A, Ortland C (2008) Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch Dermatol Res 300(2):53–60
Hauschild A, Popp G, Stockfleth E, Meyer KG, Imberger D, Mohr P, Itschert G, Kaufmann R, Neuber K, Frambach Y, Gollnick H, Brunnert M, Stocker M, Ortland C, Karrer S (2009) Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch. Exp Dermatol 18(2):116–121
Hauschild A, Stockfleth E, Popp G, Borrosch F, Bruning H, Dominicus R, Mensing H, Reinhold U, Reich K, Moor AC, Stocker M, Ortland C, Brunnert M, Szeimies RM (2009) Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 160(5):1066–1074
Szeimies RM, Stockfleth E, Popp G, Borrosch F, Bruning H, Dominicus R, Mensing H, Reinhold U, Reich K, Moor AC, Stocker M, Ortland C, Brunnert M, Hauschild A (2010) Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data. Br J Dermatol 162(2):410–414
Yoshida T, Tokashiki R, Ito H, Shimizu A, Nakamura K, Hiramatsu H, Tsukahara K, Shimizu S, Takata D, Okamoto I, Suzuki M (2008) Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration. Auris Nasus Larynx 35(4):545–551
Adelstein DJ (1998) Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer. Curr Opin Oncol 10(3):213–218
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578
Correa AJ, Burkey BB (1999) Current options in management of head and neck cancer patients. Med Clin N Am 83(1):235–246, xi
Paiva MB, Joo J, Abrahao M, Ribeiro JC, Cervantes O, Sercarz JA (2011) Update on laser photochemotherapy: an alternative for cancer treatment. Anticancer Agents Med Chem 11(8):772–779
Weisman RA, Robbins KT (1998) Management of the neck in patients with head and neck cancer treated by concurrent chemotherapy and radiation. Otolaryngol Clin N Am 31(5):773–784
Jerjes W, Upile T, Betz CS, El Maaytah M, Abbas S, Wright A, Hopper C (2007) The application of photodynamic therapy in the head and neck. Dent Update 34 (8):478–480, 483–474, 486
Biel MA (1996) Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas. Arch Otolaryngol Head Neck Surg 122(11):1261–1265
Biel MA (2002) Photodynamic therapy in head and neck cancer. Curr Oncol Rep 4(1):87–96
D’Cruz AK, Robinson MH, Biel MA (2004) mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck 26(3):232–240
Kubler A, Niziol C, Sidhu M, Dunne A, Werner JA (2005) Analysis of cost effectiveness of photodynamic therapy with Foscan (Foscan-PDT) in comparison with palliative chemotherapy in patients with advanced head-neck tumors in Germany. Laryngorhinootologie 84(10):725–732
Lorenz KJ, Maier H (2009) Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients. Eur Arch Otorhinolaryngol 266(12):1937–1944
Tan IB, Dolivet G, Ceruse P, Vander Poorten V, Roest G, Rauschning W (2010) Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study. Head Neck 32(12):1597–1604
Maier A, Tomaselli F, Matzi V, Rehak P, Pinter H, Smolle-Juttner FM (2001) Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma. Ann Thorac Surg 72(4):1136–1140
Lou PJ, Jager HR, Jones L, Theodossy T, Bown SG, Hopper C (2004) Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 91(3):441–446
Karakullukcu B, Nyst HJ, van Veen RL, Hoebers FJ, Hamming-Vrieze O, Witjes MJ, de Visscher SA, Burlage FR, Levendag PC, Sterenborg HJ, Tan IB (2012) mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: development of a new method. Head Neck 34(11):1597–1606
Harrod-Kim P (2006) Tumor ablation with photodynamic therapy: introduction to mechanism and clinical applications. J Vasc Interv Radiol 17(9):1441–1448
Jager HR, Taylor MN, Theodossy T, Hopper C (2005) MR imaging-guided interstitial photodynamic laser therapy for advanced head and neck tumors. AJNR Am J Neuroradiol 26(5):1193–1200
Jerjes W, Upile T, Hamdoon Z, Nhembe F, Bhandari R, Mackay S, Shah P, Mosse CA, Brookes JA, Morley S, Hopper C (2009) Ultrasound-guided photodynamic therapy for deep seated pathologies: prospective study. Lasers Surg Med 41(9):612–621
Wildeman MA, Nyst HJ, Karakullukcu B, Tan BI (2009) Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer. Head Neck Oncol 1:40–45
Nyst HJ, van Veen RL, Tan IB, Peters R, Spaniol S, Robinson DJ, Stewart FA, Levendag PC, Sterenborg HJ (2007) Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: phantom and volunteer experiments. Lasers Surg Med 39(8):647–653
van Veen RL, Nyst H, Rai Indrasari S, Adham Yudharto M, Robinson DJ, Tan IB, Meewis C, Peters R, Spaniol S, Stewart FA, Levendag PC, Sterenborg HJ (2006) In vivo fluence rate measurements during Foscan-mediated photodynamic therapy of persistent and recurrent nasopharyngeal carcinomas using a dedicated light applicator. J Biomed Opt 11(4):041107
Jeremic G, Moore CC, Brandt MG, Doyle PC (2011) Neoadjuvant use of photodynamic therapy in Basal cell and squamous cell carcinomas of the face. ISRN Dermatol 2011:809409
Alster TS, Tanzi EL (2003) Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol 2(5):501–504
Alster TS, Tanzi EL, Welsh EC (2005) Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 4(1):35–38
Nestor MS, Gold MH, Kauvar AN, Taub AF, Geronemus RG, Ritvo EC, Goldman MP, Gilbert DJ, Richey DF, Alster TS, Anderson RR, Bank DE, Carruthers A, Carruthers J, Goldberg DJ, Hanke CW, Lowe NJ, Pariser DM, Rigel DS, Robins P, Spencer JM, Zelickson BD (2006) The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 5(2):140–154
Bissonette R, Bergeron A, Liu Y (2004) Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol 3(1 Suppl):S26–S31
MacCormack MA (2008) Photodynamic therapy in dermatology: an update on applications and outcomes. Semin Cutan Med Surg 27(1):52–62
Zakhary K, Ellis DA (2005) Applications of aminolevulinic acid-based photodynamic therapy in cosmetic facial plastic practices. Facial Plast Surg 21(2):110–116
Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79(12):2282–2308
Alster TS, Surin-Lord SS (2006) Photodynamic therapy: practical cosmetic applications. J Drugs Dermatol 5(8):764–768
Naim R (2008) Photodynamic therapy using m-THPC (Foscan). Treatment of head and neck squamous cell carcinoma. HNO 56(5):490–492
http://www.realself.com/question/photodynamic-therapy-covered-insurance. Accessed 20 Apr 2012
WellCare Health Plans, Inc. (2011) Press release: ocular photodynamic therapy with visudyne (verteporfin) HS-031. http://www.wellcare.com/WCAssets/corporate/assets/HS031_Ocular_Photodynamic_Therapy_with_Visudyne.pdf. Accessed 20 Apr 2012
Satonaka H, Kusuzaki K, Akeda K, Tsujii M, Iino T, Uemura T, Matsubara T, Nakamura T, Asanuma K, Matsumine A, Sudo A (2011) Acridine orange inhibits pulmonary metastasis of mouse osteosarcoma. Anticancer Res 31(12):4163–4168
Tammela T, Saaristo A, Holopainen T, Yla-Herttuala S, Andersson LC, Virolainen S, Immonen I, Alitalo K (2011) Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci Transl Med 3(69):69ra11
Wen LY, Bae SM, Chun HJ, Park KS, Ahn WS (2012) Therapeutic effects of systemic photodynamic therapy in a leukemia animal model using A20 cells. Lasers Med Sci 27(2):445–452
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Vesper, B.J., Colvard, M.D. (2013). Photodynamic Therapy (PDT): An Evolving Therapeutic Technique in Head and Neck Cancer Treatment. In: Radosevich, J. (eds) Head & Neck Cancer: Current Perspectives, Advances, and Challenges. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5827-8_22
Download citation
DOI: https://doi.org/10.1007/978-94-007-5827-8_22
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5826-1
Online ISBN: 978-94-007-5827-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)